Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.400
-0.120 (-2.65%)
May 18, 2026, 4:00 PM EDT - Market closed
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $614.52 million as of May 19, 2026. Its market cap has increased by 294.11% in one year.
Market Cap
614.52M
Enterprise Value
425.72M
1-Year Change
294.11%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $614.52M, an increase of 186.55%. That is a compound annual growth rate of 10.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 614.52M | 88.43% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 681.27M |
| BridgeBio Oncology Therapeutics | 681.08M |
| Crescent Biopharma | 663.58M |
| Zevra Therapeutics | 650.86M |
| Sutro Biopharma | 645.65M |
| Candel Therapeutics | 642.58M |
| Gyre Therapeutics | 598.49M |
| CorMedix | 592.31M |